Advertisement

Epidemiology of Aging: Racial/Ethnic Specific Disease Prevalence

  • John S. Mulvahill
  • Lenise Cummings-VaughnEmail author
Chapter

Abstract

The disease incidence and prevalence in racial/ethnic minority populations are often discussed in terms of disparities. It is important to consider risk factors associated with the disease, stage of illness at the time of diagnosis, pathological presentations, and treatment. All these factors lead to prevalence of disease.

Keywords

Cancer Chronic lower respiratory disease Dementia Diabetes HIV Influenza/pneumonia Kidney disease Obesity Smoking Stroke Ethnogeriatrics Epidemiology Prevalence Incidence Aging Aged Elderly 

References

  1. 1.
    Center for Disease Control and Prevention [Internet]. Ten leading causes of death and injury; 2016 [cited 2016 Jan 30]. Available from: http://www.cdc.gov/injury/wisqars/leadingcauses.html.
  2. 2.
    Yeo G. How will the U.S. healthcare system meet the challenge of the ethnogeriatric imperative? J Am Geriatr Soc. 2009;57:1278–85.CrossRefPubMedGoogle Scholar
  3. 3.
    Conner AE, Baumgartner KB, Baumgartner RN, Pinkston CM, Boone SD, et al. Cigarette smoking and breast cancer risk in Hispanic and Non-Hispanic White women: the breast cancer health disparities study. J Womens Health (Larchmt). 2016;25(3):299–310.CrossRefGoogle Scholar
  4. 4.
    Park SY, Haiman CA, Cheng I, Park SL, Wilkens LR, Kolonel LN et al. Racial/ethnic differences in lifestyle-related factors and prostate cancer risk: the Multiethnic Cohort Study. Cancer Causes Control. 2015;26(10):1507–15. doi: 10.1007/s10552-015-0644-y.
  5. 5.
    Banderea VE, Maskarinec G, Romieu I, John EM. Racial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective. Adv Nutr. 2015;6(6):803–19. doi: 10.3945/an.115.009647.CrossRefGoogle Scholar
  6. 6.
    Stiel L, Adkins-Jackson PB, Clark P, Mitchell E, Mongomomery S. A review of hair product use on breast cancer risk in African American women. Canc Med. 2016. doi: 10.1002/cam4.613.Google Scholar
  7. 7.
    Miranda-Diaz C, Betancourt E, Ruiz-Candelaria Y, Hunter-Melldo RF. Barriers for compliance to breast, colorectal, and cervical screening cancer tests among Hispanics patients. Int J Environ Res Public Health. 2016;13(1). pii: E21. doi:  10.3390/ijerph13010021.
  8. 8.
    Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States. Cancer Med. 2003;97:1528–40.CrossRefGoogle Scholar
  9. 9.
    Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233–41.CrossRefPubMedGoogle Scholar
  10. 10.
    Watkins LO. Epidemiology and burden of cardiovascular disease. Clin Cardiol. 2004;27(S3):2–6.CrossRefGoogle Scholar
  11. 11.
    Hozawa A, Folsom AR, Sharrett AR, Chambless LE. Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with White subjects—Atherosclerosis in Communities Study. Arch Intern Med. 2007;167:573–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, et al. Lifetime risks of cardiovascular disease. N Engl J Med. 2012;366(4):321–9.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Neaton JD, Kuller LH, Wentworth D, Borhani NO. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J. 1984;108(3 Pt 2):759–69.CrossRefPubMedGoogle Scholar
  14. 14.
    Brown JM, Stewart JC, Stump TE, et al. Risk of coronary heart disease events over 15 years among older adults with depressive symptoms. Am J Geriatr Psychiatry. 2011;19:721–9.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Hooks-Anderson DR, Crannage EF, Salas J, Scherrer JF. Race and referral to diabetes education in primary care patients with prediabetes and diabetes. Diabetes Educat. 2015;41:281–9.CrossRefGoogle Scholar
  16. 16.
    Brawley OW. Prostate cancer epidemiology in the United States. World J Urol. 2012;30(2):195–200.CrossRefPubMedGoogle Scholar
  17. 17.
    Schreiber D, Chhabra A, Rineer J, Weedon J, Schwartz D. A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease? Clin Genitourin Canc. 2015;13(4):e259–64.CrossRefGoogle Scholar
  18. 18.
    Chao GF, Krishna N, Aizer AA, Dalela D, Hanske J, Li H, et al. Urol Oncol. 2015:1–9.Google Scholar
  19. 19.
    Chao GF, Krishna N, Aizer AA, Dalela D, Hanske J, Li H, et al. Asian Americans and prostate cancer: A nationwide population-based analysis. Urol Oncol. 2016;34(5):233.e7–233.e15.CrossRefGoogle Scholar
  20. 20.
    American Cancer Society. Cancer facts & figures for Hispanics/Latinos 2015-2017. Atlanta: American Cancer Society; 2015.Google Scholar
  21. 21.
    Latini DM, Elkin EP, Cooperberg MR, Sadetsky N, Duchane J, Carroll PR. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE. Cancer. 2006;106(4):789–95.CrossRefPubMedGoogle Scholar
  22. 22.
    DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin. 2013;63:151–66.CrossRefPubMedGoogle Scholar
  23. 23.
    Sineshaw HM, Gaudet M, Ward EM, Flanders WD, Desantis C, Lin CC, et al. Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011). Breast Cancer Res Treat. 2014;145(3):753–63.CrossRefPubMedGoogle Scholar
  24. 24.
    Fejerman L, Stern MC, John EM, Torres-Meija G, Hines LM, Wolff RK, et al. Interaction between common breast cancer susceptibility variants, genetic ancestry, and nongenetic risk factors in Hispanic women. Cancer Epidemiol Biomarkers Prev. 2015;24(11):1731–8.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Parsons HM, Lathrop KI, Schmidt S, Mazo-Canola M, Trevino-Jones J, Speck H, et al. Breast cancer treatment delays in a majority minority community: is there a difference? J Oncol Pract. 2015;11(2):144–53.CrossRefGoogle Scholar
  26. 26.
    Farias AJ, Du XL. Ethnic differences in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer enrolled in Medicare Part D. Med Oncol. 2016;33(2):19.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Chuang SC, Wu GJ, Lu YS, Lin CH, Hsiung CA. Associations between Medical Conditions and Breast Cancer Risk in Asians: a nationwide population-based study in Taiwan. PLoS One. 2015;10(11), e0143410.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Chuang E, Christos P, Flam A, McCarville K, Forst M, Shin S, et al. Breast cancer subtypes in Asian-Americans differ according to Asian Ethnic Group. J Immigr Minor Health. 2012;14(5):754–8.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Jackson CS, Oman M, Patel AM, Vega KJ. Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gasterointest Oncol. 2016;7 Suppl 1:S32–43.Google Scholar
  30. 30.
    Andaya AA, Enewold L, Zahm SH, Shriver CD, Stojadivonvic AL, McGlynn KA, et al. Race and colon Cancer Survival in an Equal-Access Health Care System. Cancer Epidemiol Biomarkers Prev. 2013;22(6):1030–6.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Laiyemo AO, Thompson N, Williams CD, Idowu KA, Bull-Henry K, et al. Race and colorectal cancer screening compliance among persons with a family history of cancer. World J Gastrointest Endosc. 2015;7(18):1300–5.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    American Cancer Society. Cancer facts & figures 2016. Atlanta: American Cancer Society; 2016.Google Scholar
  33. 33.
    Robbins AS, Siegel RL, Jemal A. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol. 2012;30:401–5.CrossRefPubMedGoogle Scholar
  34. 34.
    Lewis DR, Check DP, Caporaso NE, Travis WD, Devesa SS. US lung cancer trends by histologic type. Cancer. 2014;120(18):2883–92.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Patel MI, Cheng I, Gomez SL. US lung cancer trends by histologic type. Cancer. 2015;121(7):1150–2.CrossRefPubMedGoogle Scholar
  36. 36.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.CrossRefPubMedGoogle Scholar
  37. 37.
    Bollig-Fischer A, Chen W, Gadgeel SM, Wenzlaff AS, Cote ML, Schwartz AG, Bepler G. Racial diversity of actionable mutations in non–small cell lung cancer. J Thorac Oncol. 2015;10(2):250–5.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Prizment AE, Yatsuya H, Lutsey PL, Lubin JH, Woodward M, Folsom AR, Huxley RR. Smoking behavior and lung cancer in a biracial cohort: the atherosclerosis risk in communities study. Am J Prev Med. 2014;46(6):624–32.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Cress WD, Chiappori A, Santiago P, Muñoz-Antonia T. Lung cancer mutations and use of targeted agents in Hispanics. Rev Recent Clin Trials. 2014;9(4):225.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Ha SY, Choi SJ, Cho JH, Choi HJ, Lee J, Jung K, Irwin D, Liu X, Lira ME, Mao M, Kim HK. Lung cancer in neversmoker Asian females is driven by oncogenic mutations, most often involving EGFR. Oncotarget. 2015;6(7):5465.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Fang B, Mehran RJ, Heymach JV, Swisher SG. Predictive biomarkers in precision medicine and drug development against lung cancer. Chin J Canc. 2015;34(3):1.CrossRefGoogle Scholar
  42. 42.
    Steuer CE, Behera M, Berry L, Kim S, Rossi M, Sica G, et al. Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium. Cancer. 2015;122(5):766–72.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Araujo LH, Timmers C, Bell EH, Shilo K, Lammers PE, Zhao W et al. Genomic characterization of non–small-cell lung cancer in African Americans by targeted massively parallel sequencing. J Clin Oncol. 2015: published online ahead of print.Google Scholar
  44. 44.
    American Cancer Society. Cancer facts & figures 2011. Special section: Cancer disparities and premature deaths; 2011 [cited 2016 Apr 22]. Available from: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-038826.pdf.
  45. 45.
    DeSantis CE, Siegel RL, Sauer AG, Miller KD, et al. Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin. 2016. doi: 10.3322/caac.21340.Google Scholar
  46. 46.
    Martin A, Badrick E, Mathur R, Hull S. Effect of ethnicity on the prevalence, severity, and management of COPD in general practice. Br J Gen Pract. 2012. doi: 10.3399/bjgp12X625120.Google Scholar
  47. 47.
    Chatila WM, Wynkoof WA, Vance GV, Criner GJ. Smoking patterns in African Americans and Whites with advanced COPD. Chest. 2004;125:15–21.CrossRefPubMedGoogle Scholar
  48. 48.
    Tran HN, Siu S, Iribarren C, Udaltsova N, Klatsky AL. Ethnicity and risk of hospitalization for asthma and chronic obstructive pulmonary disease. Ann Epidemiol. 2011;21:615–22.CrossRefPubMedGoogle Scholar
  49. 49.
    Allen CJ, Hannay WM, Murray CR, Straker RJ, et al. Causes of death differ between elderly and adult falls. J Trauma Acute Care Surg. 2015;79(4):617–21.CrossRefPubMedGoogle Scholar
  50. 50.
    Albert M, McCaig LF, Ashman JJ. Emergency department visits by persons aged 65 and over: United States, 2009–2010. NCHS data brief, no 130. Hyattsville, MD: National Center for Health Statistics. 2013.Google Scholar
  51. 51.
    Stevens JA, Hasbrouck L, Durant TM, Dellinger AM, et al. Surveillance for injuries and violence among older adults. MMWR Surveill Summ. 1999;48(S S09):27–50.Google Scholar
  52. 52.
    Bhat G, Naumann RB. Travel-related behaviors, opinions, and concerns of U.S. adult drivers by race/ethnicity, 2010. J Saf Res. 2013;47:93–7.CrossRefGoogle Scholar
  53. 53.
    Feldmeyer B, Steffensmeier D. Patterns and trends in elder homicide across race and ethnicity, 1985-2009. Homicide Stud. 2013;17(2):204–23.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Centers for Disease Control and Prevention. Diabetes—United States, 2006 and 2010. Morb Mortal Wkly Rep. 2013;62:99–104.Google Scholar
  55. 55.
    Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–322.CrossRefPubMedGoogle Scholar
  56. 56.
    Howard G, Goff DC. Population shifts and the future of stroke: forecasts of the future burden of stroke. Ann N Y Acad Sci. 2012;1268(1):14–20.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Morgenstern LB, Smith MA, Lisabeth LD, Risser JM, Uchino K, Garcia N, et al. Excess Stroke in Mexican Americans Compared with Non-Hispanic Whites The Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol. 2004;160(4):376–83.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Morgenstern LB, Smith MA, Sánchez BN, Brown DL, Zahuranec DB, Garcia N, et al. Persistent ischemic stroke disparities despite declining incidence in Mexican Americans. Ann Neurol. 2013;74(6):778–85.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Henderson SO, Haiman CA, Wilkens LR, Kolonel LN, Wan P, Pike MC. Established risk factors account for most of the racial differences in cardiovascular disease mortality. PLoS One. 2007;2(4), e377.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Zhang Y, Galloway JM, Welty TK, Wiebers DO, Whisnant JP, Devereux RB, et al. Incidence and risk factors for stroke in American Indians: The Strong Heart study. Circulation. 2008;118(15):1577–84.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Northern Manhattan Stroke Study Collaborators (NMSSC), Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, et al. Stroke incidence among White, AA, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol. 1998;147(3):259–68.CrossRefGoogle Scholar
  62. 62.
    Tsai CF, Thomas B, Sudlow CL. Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review. Neurology. 2013;81(3):264–72.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Kleindorfer DO, Khoury J, Moomaw CJ, Alwell K, Woo D, Flaherty ML, et al. Stroke incidence is decreasing in Whites but not in Blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke. 2010;41(7):1326–31.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Morgenstern LB, Kissela BM. Stroke disparities: large global problem that must be addressed. Stroke. 2015;46(12):3560–3.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Sevush-Garcy J, Gutierrez J. An epidemiological perspective on race/ethnicity and stroke. Curr Cardiovasc Risk Rep. 2015;9:1–10.CrossRefGoogle Scholar
  66. 66.
    Howard VJ, McClure LA, Meschia JF, Pulley L, Orr SC, Friday GH. High prevalence of stroke symptoms among persons without a diagnosis of stroke or transient ischemic attack in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Arch Intern Med. 2006;166(18):1952–8.CrossRefPubMedGoogle Scholar
  67. 67.
    Marcus GM, Alonso A, Peralta CA, Lettre G, Vittinghoff E, Lubitz SA, et al. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation. 2010;122(20):2009–15.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 2003;290(8):1049–56.CrossRefPubMedGoogle Scholar
  69. 69.
    Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–8.CrossRefPubMedGoogle Scholar
  70. 70.
    Qian F, Fonarow GC, Smith EE, Xian Y, Pan W, Hannan EL, et al. Racial and ethnic differences in outcomes in older patients with acute ischemic stroke. Circ Cardiovasc Qual Outcomes. 2013;6(3):284–92.CrossRefPubMedGoogle Scholar
  71. 71.
    Burke JF, Freedman VA, Lisabeth LD, Brown DL, Haggins A, Skolarus LE. Racial differences in disability after stroke: results from a nationwide study. Neurology. 2014;83(5):390–7.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Fei K, Benn EK, Negron R, Arniella G, Tuhrim S, Horowitz CR. Prevalence of depression among stroke survivors: racial–ethnic differences. Stroke. 2015;47:1–4.Google Scholar
  73. 73.
    Steenland K, et al. A meta-analysis of Alzheimer’s disease incidence and prevalence comparing African-Americans and Caucasians. J Alzheimers Dis. 2016;50(1):71–6.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Mehta KM, Yaffe K, Pérez-Stable EJ, Stewart A, Barnes D, Kurland BF, et al. Race/ethnic differences in AD survival in US Alzheimer’s Disease Centers. Neurology. 2008;70:1163–70.CrossRefPubMedGoogle Scholar
  75. 75.
    Mayeda ER, Glymour MM, Quesenberry CP, Whitmer RA. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dementia. 2016;12:216–24.CrossRefGoogle Scholar
  76. 76.
    Barnes LL, Bennett DA. Alzheimer’s disease in African Americans: risk factors and challenges for the future. Health Aff (Millwood). 2014;33:580–6.CrossRefGoogle Scholar
  77. 77.
    Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202:329–35.CrossRefPubMedPubMedCentralGoogle Scholar
  78. 78.
    Machado A, Herrera AJ, de Pablos RM, et al. Chronic stress as a risk factor for Alzheimer’s disease. Rev Neurosci. 2014;25:785–804.CrossRefPubMedGoogle Scholar
  79. 79.
    Dilworth-Anderson P, Hendrie HC, Manly JJ, et al. Diagnosis and assessment of Alzheimer’s disease in diverse populations. Alzheimers Dement. 2008;4(4):305–9.CrossRefPubMedGoogle Scholar
  80. 80.
    Campbell NL, Cantor BB, Hui SL. Race and documentation of cognitive impairment among hospitalized elders. J Am Geriatr Soc. 2014;62(3):506–11.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Reitz C, Jun G, Naj A, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipo protein E e4 and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013;309(14):1483–92.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipo protein E genotype and Alzheimer disease: a meta-analysis. JAMA. 1997;278(16):1349–56.CrossRefPubMedGoogle Scholar
  83. 83.
    Wu P, Li HL, Liu ZJ, Tao QQ, Xu M, Guo QH, et al. Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population. Clin Interv Aging. 2015;10:371–8.PubMedPubMedCentralGoogle Scholar
  84. 84.
    Fujioka H, Phelix C, Friedland R, Zhu X, Perry E, Castellani R, et al. Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer's disease. J Health Care Poor Underserved. 2013;24(4):70–8.PubMedPubMedCentralGoogle Scholar
  85. 85.
    Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998;279:751–5.CrossRefPubMedGoogle Scholar
  86. 86.
    Kim YJ, Han JW, So YS, Seo JY, Kim KY, Kim KW. Prevalence and trends of dementia in Korea: a systematic review and meta-analysis. J Korean Med Sci. 2014;29(7):903–12.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Haan MN, Mungas DM, Gonzalez HM, et al. Prevalence of dementia in older Latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc. 2003;51:169–77.CrossRefPubMedGoogle Scholar
  88. 88.
    Centers for Disease Control and Prevention (CDC). Diabetes Public Health Resource: Diagnosed Diabetes [Internet]. Atlanta, Georgia: Centers for Disease Control and Prevention (US); 2015 [Cited 2016 Mar 29]. Available from: http://www.cdc.gov/diabetes/statistics/prevalence_national.htm.
  89. 89.
    Spanakis EK, Golden SH. Race/ethnic difference in diabetes and diabetic complications. Curr Diabetes Rep. 2013;13(6):814–23.CrossRefGoogle Scholar
  90. 90.
    Piccolo RS, Pearce N, Araujo AB, McKinlay JB. The contribution of biogeographical ancestry and socioeconomic status to racial/ethnic disparities in type 2 diabetes mellitus: results from the Boston Area Community Health Survey. Ann Epidemiol. 2014;24(9):648–54.CrossRefPubMedPubMedCentralGoogle Scholar
  91. 91.
    Chatterjee R, Brancati FL, Shafi T, Edelman D, Pankow JS, Mosley TH, et al. Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study. J Gen Intern Med. 2014;29(2):290–7.CrossRefPubMedGoogle Scholar
  92. 92.
    Chatterjee R, Maruthur NM, Edelman D. Novel Risk Factors for Type 2 Diabetes in African-Americans. Curr Diabetes Rep. 2015;15(12):1.CrossRefGoogle Scholar
  93. 93.
    Karter AJ, Laiteerapong N, Chin MH, Moffet HH, Parker MM, Sudore R, et al. Ethnic differences in geriatric conditions and diabetes complications among older, insured adults with diabetes the diabetes and aging study. J Aging Health. 2015;27(5):894–918.CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Hazel-Fernandez L, Li Y, Nero D, Moretz C, Slabaugh L, Meah Y, et al. Racial/ethnic and gender differences in severity of diabetes-related complications, health care resource use, and costs in a Medicare population. Popul Health Manag. 2015;18(2):115–22.CrossRefPubMedGoogle Scholar
  95. 95.
    Williams LK, Padhukasahasram B, Ahmedani BK, Peterson EL, Wells KE, González Burchard E, et al. Differing effects of metformin on glycemic control by race-ethnicity. J Clin Endocrinol Metabol. 2014;99(9):3160–8.CrossRefGoogle Scholar
  96. 96.
    Davidson J, Lacaya L, Jiang H, Heilmann C, Scism-Bacon J, Gates J, et al. Impact of race/ethnicity on the efficacy and safety of commonly used insulin regimens: a post hoc analysis of clinical trials in type 2 diabetes mellitus. Endocr Pract. 2010;16(5):818–28.CrossRefPubMedGoogle Scholar
  97. 97.
    Simonetti JA, Fine MJ, Chen YF, Simak D, Hess R. Racial comparisons of diabetes care and intermediate outcomes in a patient-centered medical home. Diabetes Care. 2014;37(4):993–1001.CrossRefPubMedPubMedCentralGoogle Scholar
  98. 98.
    Hazel-Fernandez L, Xu Y, Moretz C, Meah Y, Baltz J, Lian J, et al. Historical cohort analysis of treatment patterns for patients with type 2 diabetes initiating metformin monotherapy. Curr Med Res Opin. 2015;31(9):1703–16.CrossRefPubMedGoogle Scholar
  99. 99.
    Chow W, Buysman E, Rupnow MF, Aguilar R, Henk HJ. Canagliflozin treatment of Hispanic and non-Hispanic patients with type 2 diabetes in a US managed care setting. Curr Med Res Opin. 2016;32(1):13–22.CrossRefPubMedGoogle Scholar
  100. 100.
    Singleton JA, Santibanez TA, Wortley PM. Influenza and pneumococcal vaccination of adults aged ≥65: racial/ethnic differences. Am J Prev Med. 2005;29(5):412–20.CrossRefPubMedGoogle Scholar
  101. 101.
    Lu PJ, O’Halloran A, Williams WW, Lindley MC, Farrall S, Bridges CB. Racial and ethnic disparities in vaccination coverage among adult populations in the US. Am J Prev Med. 2015;49(6):S412–25.CrossRefPubMedGoogle Scholar
  102. 102.
    Herbert PL, Frick KD, Kane RL, McBean AM. The causes of racial and ethnic differences in influenza vaccination rates among elderly medicare beneficiaries. Health Serv Res. 2005;40(2):517–37.CrossRefGoogle Scholar
  103. 103.
    United States Renal Data System. 2015 USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2015.Google Scholar
  104. 104.
    Lopes AA. Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure. Adv Ren Replace Ther. 2004;11(1):14–23.CrossRefPubMedGoogle Scholar
  105. 105.
    Centers for Disease Control and Prevention [Internet]. Estimated HIV incidence in the United States 2007–2010. HIV Surveillance Supplemental Report. 2012;17(4). Available from: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/#supplemental.
  106. 106.
    Siddiqi AE, Hu X, Hall H. Mortality among blacks or African Americans with HIV infection—United States, 2008-2012. MMWR Morb Mortal Wkly Rep. 2015;64(4):81–6.PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Division of Geriatrics and Nutritional ScienceWashington University in Saint Louis, School of MedicineSt. LouisUSA

Personalised recommendations